eosinophilic

Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

e·o·sin·o·phil·ic

(ē′ə-sĭn′ə-fĭl′ĭk)

adj.

1. Easily stained by eosin or other acid dyes. Used of a cell or cell structure.

2. Of or relating to eosinophils.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

e•o•sin•o•phil•ic

(ˌi əˌsɪn əˈfɪl ɪk)

also e•o•si•noph•i•lous

(-sɪˈnɒf ə ləs)

eosinophil,

adj.

having an affinity for eosin and other acid dyes; acidophilic.

[1895–1900]

ThesaurusAntonymsRelated WordsSynonymsLegend:

Switch to new thesaurus

Adj.

eosinophilic - of or relating to eosinophil

Translations

e·o·sin·o·phil·ic

a. eosinófilo-a, que tiene afinidad con o por la eosina.

English-Spanish Medical Dictionary © Farlex 2012

Mentioned in ?

References in periodicals archive ?

Atlanta, GA, September 01, 2019 --(PR.com)-- The American Partnership for Eosinophilic Disorders (APFED), a non-profit advocacy organization established in 2001, offers a wealth of free resources and tools online to support children with eosinophilic-associated diseases in a school environment.

Supporting Students with Eosinophil-Associated Disease at School

The US Food and Drug Administration has granted orphan drug designation to United Kingdom-based AstraZeneca's Fasenra (benralizumab) intended for the treatment of eosinophilic oesophagitis, it was reported yesterday.

US FDA grants orphan drug designation to AstraZeneca's Fasenra

Global Banking News-August 29, 2019-AstraZeneca's Fasenra granted Orphan Drug Designation by US FDA for eosinophilic oesophagitis

AstraZeneca's Fasenra granted Orphan Drug Designation by US FDA for eosinophilic oesophagitis

ENPNewswire-August 20, 2019--Knopp Biosciences Announces Start of Phase 2 Clinical Trial Evaluating Oral Dexpramipexole in Moderate-to-Severe Eosinophilic AsthmaAugust 19, 2019

Knopp Biosciences Announces Start of Phase 2 Clinical Trial Evaluating Oral Dexpramipexole in Moderate-to-Severe Eosinophilic AsthmaAugust 19, 2019

This is the only monthly* anti-IL5 biologic approved in Europe that people with severe eosinophilic asthma can take at home, after a healthcare professional decides it is appropriate.

GlaxoSmithKline (LSE: GSK) - Nucala receives EU approval for self-administration by patients with severe eosinophilic asthma -- 1/8/2019

Shares of Allakos are down over 25% in the past month, while short interest has increased to just above 30% of the company's float, due to concerns about the late July or early August readout from the Phase II Enigma trial of AK002 for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis, William Blair analyst Tim Lugo tells investors in a research note.

Some bear arguments on Allakos trial unfounded, says William Blair

A total of 34% of children who underwent solid organ transplantation subsequently developed eczema, food allergy, rhinitis, eosinophilic gastrointestinal disease, or asthma, according to the results of a single-center retrospective cohort study.

Allergy, eczema common after pediatric solid organ transplantation

Eosinophilic fasciitis (EF) or Shulman syndrome, is a scleroderma-like syndrome with an early phase characterized by erythema and edema distributed over the limbs or trunk and a later phase, dominated by collagenous thickening of the subcutaneous fascia.

Eosinophilic fasciitis associated with factor V Leiden: a case report

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease that is mediated by immunogenic/antigenic (primarily food allergen) mechanisms.

Serum eosinophilic cationic protein is correlated with food impaction and endoscopic severity in eosinophilic esophagitis

Fasenra, made by AstraZeneca, targets and depletes the immune cells in the blood which cause the condition eosinophilic asthma.

New treatment for asthma

Dr Samantha Walker, director of research and policy at charity Asthma UK, said: "Benralizumab is one of a group of life-changing drugs which have the power to improve the lives of thousands of people suffering from severe eosinophilic asthma."